Filter News

BioCareSD Adds Six New Products to Existing Portfolio in Partnership with UCB

Published: Oct 04, 2022

Leading Specialty Distributor Contracts with Global Biopharmaceutical Company to Significantly Expand Patient Populations Served

 

TEMPE, Ariz. – October 3, 2022 – BioCareSD, a specialty distributor of life-saving therapies, today announced a contract with UCB to add six new product offerings to its already diverse portfolio. This partnership, which will enable BioCareSD to service a wider patient population, demonstrates the organization’s continued commitment to being the industry’s most trusted healthcare partner.

 

Now available through BioCareSD’s specialty distribution network, the six new products include:

  • BRIVIACT® - partial-onset seizures in patients one month of age and older
  • CIMZIA® - Crohn’s Disease and Rheumatoid Arthritis
  • NAYZILAM® - intermittent, stereotypic episodes of frequent seizure activity, distinct from patient’s usual seizure pattern in patients with epilepsy 12 years of age and older
  • NEUPRO® - Parkinson’s Disease and Restless Leg Syndrome
  • KEPPRA® - partial-onset seizures in adults with epilepsy
  • VIMPAT® - partial-onset seizures in patients with epilepsy 17 years of age and older

 

Dedicated to ensuring life-sustaining therapies are delivered to patients with ultra-rare, rare and orphan diseases where and when they are needed, BioCareSD is trusted by manufacturers and healthcare providers nationwide. As one of the original specialty distributors, BioCareSD has developed an extremely reliable and fast distribution network, with the ability to deliver within a six-hour window.

 

“We are consistently looking for ways to better serve our customers and expand into patient populations whose needs are currently unmet,” said Andrew Kirk, chief revenue officer at BioCareSD. “This incredible opportunity to work with UCB has allowed us to increase patient access to much-needed and potentially life-saving therapeutics, which is of the utmost importance.”

 

BioCareSD will continue to diversify its product offerings to meet customer demand and help ensure the highest quality patient care.

 

For more information, please visit www.biocaresd.com. 

 

About BioCareSD 

BioCareSD is a leading national specialty distributor of life-saving therapies. Headquartered in Phoenix, Arizona, BioCareSD has been devoted to delivering specialty and therapeutic biological products since 1982. BioCareSD is part of BioCare, Inc., which also encompasses CanyonCareRX, a full-service specialty pharmacy, LogiCare3PL, a national provider of time and temperature-sensitive pharmaceutical logistics services, and QRCare, a quality and regulatory consultancy service. BioCare, Inc. was included on the Inc. 5000 Fastest-Growing Private Companies in America list in 2022. For more information about BioCareSD, please visit www.biocaresd.com.

### 

 

Media Contact:  
Macy Hyland, Crowe PR  
mhyland@crowepr.com | 541.556.4054 

Back to news